SCHEMBL6323112

SCHEMBL6323112

Nc1ccc(C(=O)n2cccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HPGD P15428 2/20 0.52
HTT P42858 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MAPT P10636 2/20 0.52
ALDH1A1 P00352 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
P2RX4 Q99571 1/20 0.47
ENPP3 O14638 3/20 0.43
ALPL P05186 3/20 0.43
XIAP P98170 3/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
AVPR2 P30518 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3895806 0.80 TSHR (0.55) SMN1; SMN2ALDH1A1CA12CA1CA2
SCHEMBL946095 0.79 TSHR (0.48) LMNAHPGDMAPTALDH1A1P2RX4
SCHEMBL31068112 0.78 HPGD (0.52) HPGDCA12CA1CA2CA7
SCHEMBL1892160 0.77 TSHR (0.47) LMNAHPGDMAPTALDH1A1P2RX4
Methyl Alcohol SCHEMBL27278041 0.76 TSHR (0.46) LMNAHPGDMAPTALDH1A1P2RX4
SCHEMBL25931829 0.75 CYP19A1 (0.55) LMNAMEN1KMT2AHPGDHTT
SCHEMBL7588496 0.74 HPGD (0.56) MEN1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL6325746 0.72 CES1 (0.57) HPGDSMN1; SMN2ALDH1A1P2RX4CA12
SCHEMBL20261717 0.71 CA12 (0.73) LMNAMEN1KMT2AHPGDHTT
SCHEMBL27386714 0.71 L3MBTL1 (0.42) LMNAHPGDSMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124664-A1 Urea thiadiazole inhibitors of plasminogen activator inhibior-1 BRISTOL-MYERS SQUIBB CO. 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124664-A1 Urea thiadiazole inhibitors of plasminogen activator inhibior-1 SERPINE1, SERPINC1, SERPINB1 LMNA 1497/4885MEN1 1004/4885KMT2A 4128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.